Efficient RNAi-induced Protein Knockdown in Somatic Cells Using Diced or Chemically Produced Small Interfering RNAs (siRNA)
暂无分享,去创建一个
C. Ambrósio | J. Murray | E. Maga | M. Bertolini | L. Bertolini | K. Tavares | L. Aguiar | C. E. M. Calderón | L. T. Martins | R. M. Pinho | I. S. Carneiro | Luís Henrique de Aguiar
[1] Zhihong Zhang,et al. Cell‐selective gene silencing in prostate cancer LNCap cells using prostate‐specific membrane antigen promoter and enhancer in vitro and in vivo , 2012, Cell biology international.
[2] A. Belayew,et al. On-chip microelectrophoresis for the study of in vitro nonhomologous end-joining DNA double-strand break repair. , 2012, Analytical biochemistry.
[3] Yuan Luo,et al. The SID-1 double-stranded RNA transporter is not required for systemic RNAi in the migratory locust , 2012, RNA biology.
[4] Karol Kozak,et al. Z’ Factor including siRNA design quality parameter in RNAi screening experiments , 2012, RNA biology.
[5] Takashi Kohno,et al. Essential Factors for Incompatible DNA End Joining at Chromosomal DNA Double Strand Breaks In Vivo , 2011, PloS one.
[6] May P. Xiong,et al. Non-cell-autonomous RNA interference in mammalian cells: Implications for in vivo cell-based RNAi delivery , 2011, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research.
[7] M. Peoples,et al. Production of Transgenic Calves Expressing an shRNA Targeting Myostatin , 2011, Molecular reproduction and development.
[8] N. Curtin,et al. Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K , 2011, Molecular Cancer Therapeutics.
[9] C. Hsieh,et al. Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy , 2011, The Prostate.
[10] M. Zamora,et al. RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. , 2011, American journal of respiratory and critical care medicine.
[11] E. Kass,et al. Collaboration and competition between DNA double‐strand break repair pathways , 2010, FEBS letters.
[12] Robert Langer,et al. Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.
[13] J. Murray,et al. Increased Gene Targeting in Ku70 and Xrcc4 Transiently Deficient Human Somatic Cells , 2009, Molecular biotechnology.
[14] John J. Rossi,et al. The promises and pitfalls of RNA-interference-based therapeutics , 2009, Nature.
[15] A. Aguilera,et al. DNA Repair in Mammalian Cells , 2009, Cellular and Molecular Life Sciences.
[16] T. Honda,et al. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase. , 2008, International journal of oncology.
[17] E. Hendrickson,et al. Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells , 2008, Proceedings of the National Academy of Sciences.
[18] S. Beaucage. Solid-phase synthesis of siRNA oligonucleotides. , 2008, Current opinion in drug discovery & development.
[19] E. Pastwa,et al. Non-homologous DNA end joining in anticancer therapy. , 2007, Current cancer drug targets.
[20] J. Murray,et al. Transient depletion of Ku70 and Xrcc4 by RNAi as a means to manipulate the non-homologous end-joining pathway. , 2007, Journal of biotechnology.
[21] P. Opolon,et al. Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. , 2006, Human gene therapy.
[22] R. E. Foster,et al. Monoubiquitination of the nonhomologous end joining protein XRCC4. , 2006, Biochemical and biophysical research communications.
[23] Anastasia Khvorova,et al. 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets , 2006, Nature Methods.
[24] J. Puymirat,et al. RNA based gene therapy for dominantly inherited diseases. , 2006, Current gene therapy.
[25] T. Sakurai,et al. Blockade of bulky lymphoma‐associated CD55 expression by RNA interference overcomes resistance to complement‐dependent cytotoxicity with rituximab , 2006, Cancer science.
[26] Assam El-Osta,et al. RNA interference and potential therapeutic applications of short interfering RNAs , 2005, Cancer Gene Therapy.
[27] Terran Lane,et al. A computational study of off-target effects of RNA interference , 2005, Nucleic acids research.
[28] J. Kaplan,et al. Stable Plasma Membrane Levels of hCTR1 Mediate Cellular Copper Uptake* , 2005, Journal of Biological Chemistry.
[29] H. Soifer,et al. A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon , 2005, Nucleic acids research.
[30] D. V. van Gent,et al. The mechanism of non-homologous end-joining: a synopsis of synapsis. , 2004, DNA repair.
[31] B. Williams,et al. RNA interference and double-stranded-RNA-activated pathways. , 2004, Biochemical Society transactions.
[32] M. Wood,et al. RNA interference: from model organisms towards therapy for neural and neuromuscular disorders. , 2004, Human molecular genetics.
[33] Y. Li,et al. Genome-wide expression profiling of RNA interference of hepatitis B virus gene expression and replication , 2004, Cellular and Molecular Life Sciences CMLS.
[34] Tyra G. Wolfsberg,et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Wood,et al. Survival of motor neuron gene downregulation by RNAi: towards a cell culture model of spinal muscular atrophy. , 2004, Brain research. Molecular brain research.
[36] John J Rossi,et al. Approaches for the sequence-specific knockdown of mRNA , 2003, Nature Biotechnology.
[37] K. Valerie,et al. Regulation and mechanisms of mammalian double-strand break repair , 2003, Oncogene.
[38] S. Fesik,et al. Specificity of short interfering RNA determined through gene expression signatures , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[39] E. Southern,et al. A simple and cost-effective method for producing small interfering RNAs with high efficacy. , 2003, Nucleic acids research.
[40] Joshua T. Jones,et al. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing , 2003, Nature Biotechnology.
[41] F. Buchholz,et al. Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] Stacy L DeRuiter,et al. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[43] R. Schultz,et al. RNAi in mouse oocytes and preimplantation embryos: effectiveness of hairpin dsRNA. , 2001, Biochemical and biophysical research communications.
[44] T. Tuschl,et al. RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.
[45] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[46] A. Joyner,et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.
[47] M. Satoh,et al. Role of free p70 (Ku) subunit in posttranslational stabilization of newly synthesized p80 during DNA-dependent protein kinase assembly. , 1995, European journal of cell biology.
[48] P. Jeggo,et al. X-ray-sensitive mutants of Chinese hamster ovary cell line. Isolation and cross-sensitivity to other DNA-damaging agents. , 1983, Mutation research.
[49] P. Linsley,et al. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application , 2010, Nature Reviews Drug Discovery.